The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Atlantic Biologicals sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Atlantic Biologicals Corp (Atlantic Biologicals) is a distributor of brand, generic and critical care pharmaceuticals. The company offer products such as liquid cups, powders, solids, ointment syringes and oral syringes. It offers distribution services for prepackaged unit dose items, which include oral liquid cups, oral liquid syringes, solid single pill pack, and powders. Atlantic Biologicals provides pharmaceutical supply chain and atlantic biologicals. Its serves hospitals, physicians’ offices, oncology clinics, diagnostic centers, freestanding clinics, and home infusion facilities. The company offers its products across Arizona, North Carolina, Florida, Tennessee, Maryland, and Texas. Atlantic Biologicals is headquartered in Miami, Florida, the US.
The key metrics of Atlantic Biologicals related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Atlantic Biologicals is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Atlantic Biologicals.
For a detailed understanding of the performance of Atlantic Biologicals, buy the report here.